nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—RPS6KB1—primary biliary cirrhosis	0.358	0.547	CbGaD
Crizotinib—TYK2—primary biliary cirrhosis	0.296	0.453	CbGaD
Crizotinib—Acute respiratory distress syndrome—Colchicine—primary biliary cirrhosis	0.00662	0.0621	CcSEcCtD
Crizotinib—Generalised oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00261	0.0245	CcSEcCtD
Crizotinib—Generalised oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00261	0.0245	CcSEcCtD
Crizotinib—Transaminases increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00255	0.0239	CcSEcCtD
Crizotinib—Transaminases increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00255	0.0239	CcSEcCtD
Crizotinib—Interstitial lung disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.00219	0.0206	CcSEcCtD
Crizotinib—Interstitial lung disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.00219	0.0206	CcSEcCtD
Crizotinib—PRKD1—smooth muscle tissue—primary biliary cirrhosis	0.00196	0.03	CbGeAlD
Crizotinib—Gamma-glutamyltransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00189	0.0177	CcSEcCtD
Crizotinib—Gamma-glutamyltransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00189	0.0177	CcSEcCtD
Crizotinib—MET—epithelium—primary biliary cirrhosis	0.00169	0.0259	CbGeAlD
Crizotinib—Fluid retention—Ursodeoxycholic acid—primary biliary cirrhosis	0.00147	0.0138	CcSEcCtD
Crizotinib—Fluid retention—Chenodeoxycholic acid—primary biliary cirrhosis	0.00147	0.0138	CcSEcCtD
Crizotinib—Hepatic function abnormal—Colchicine—primary biliary cirrhosis	0.00144	0.0135	CcSEcCtD
Crizotinib—BMPR1B—epithelium—primary biliary cirrhosis	0.00135	0.0207	CbGeAlD
Crizotinib—IGF1R—epithelium—primary biliary cirrhosis	0.00133	0.0203	CbGeAlD
Crizotinib—Blood alkaline phosphatase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.0013	0.0122	CcSEcCtD
Crizotinib—Blood alkaline phosphatase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.0013	0.0122	CcSEcCtD
Crizotinib—TIE1—epithelium—primary biliary cirrhosis	0.00129	0.0198	CbGeAlD
Crizotinib—Hepatic function abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00129	0.0121	CcSEcCtD
Crizotinib—Hepatic function abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00129	0.0121	CcSEcCtD
Crizotinib—IGF1R—smooth muscle tissue—primary biliary cirrhosis	0.00128	0.0196	CbGeAlD
Crizotinib—NEK9—liver—primary biliary cirrhosis	0.00126	0.0193	CbGeAlD
Crizotinib—TIE1—smooth muscle tissue—primary biliary cirrhosis	0.00124	0.0191	CbGeAlD
Crizotinib—SIK2—liver—primary biliary cirrhosis	0.00113	0.0174	CbGeAlD
Crizotinib—Aspartate aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00113	0.0106	CcSEcCtD
Crizotinib—Diplopia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00113	0.0106	CcSEcCtD
Crizotinib—Diplopia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00113	0.0106	CcSEcCtD
Crizotinib—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00111	0.0104	CcSEcCtD
Crizotinib—Muscular weakness—Colchicine—primary biliary cirrhosis	0.00111	0.0104	CcSEcCtD
Crizotinib—PRKD3—liver—primary biliary cirrhosis	0.00111	0.0169	CbGeAlD
Crizotinib—Face oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00109	0.0102	CcSEcCtD
Crizotinib—Face oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00109	0.0102	CcSEcCtD
Crizotinib—RIPK2—epithelium—primary biliary cirrhosis	0.00106	0.0162	CbGeAlD
Crizotinib—CASK—liver—primary biliary cirrhosis	0.00106	0.0162	CbGeAlD
Crizotinib—PTK2B—smooth muscle tissue—primary biliary cirrhosis	0.00103	0.0158	CbGeAlD
Crizotinib—Aspartate aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00952	CcSEcCtD
Crizotinib—Aspartate aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00952	CcSEcCtD
Crizotinib—Neutropenia—Colchicine—primary biliary cirrhosis	0.00101	0.00951	CcSEcCtD
Crizotinib—FES—liver—primary biliary cirrhosis	0.00101	0.0155	CbGeAlD
Crizotinib—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000994	0.00933	CcSEcCtD
Crizotinib—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000994	0.00933	CcSEcCtD
Crizotinib—PTK2—epithelium—primary biliary cirrhosis	0.000984	0.0151	CbGeAlD
Crizotinib—MET—liver—primary biliary cirrhosis	0.000956	0.0147	CbGeAlD
Crizotinib—PTK2—smooth muscle tissue—primary biliary cirrhosis	0.000949	0.0145	CbGeAlD
Crizotinib—Neuropathy peripheral—Colchicine—primary biliary cirrhosis	0.000948	0.00889	CcSEcCtD
Crizotinib—RPS6KB1—epithelium—primary biliary cirrhosis	0.000947	0.0145	CbGeAlD
Crizotinib—TYK2—smooth muscle tissue—primary biliary cirrhosis	0.000942	0.0144	CbGeAlD
Crizotinib—IRAK1—smooth muscle tissue—primary biliary cirrhosis	0.00093	0.0142	CbGeAlD
Crizotinib—CDK7—liver—primary biliary cirrhosis	0.000925	0.0142	CbGeAlD
Crizotinib—TAOK2—liver—primary biliary cirrhosis	0.000918	0.0141	CbGeAlD
Crizotinib—RPS6KB1—smooth muscle tissue—primary biliary cirrhosis	0.000912	0.014	CbGeAlD
Crizotinib—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000906	0.00849	CcSEcCtD
Crizotinib—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000906	0.00849	CcSEcCtD
Crizotinib—AXL—smooth muscle tissue—primary biliary cirrhosis	0.000903	0.0138	CbGeAlD
Crizotinib—EPHB4—epithelium—primary biliary cirrhosis	0.000896	0.0137	CbGeAlD
Crizotinib—JAK2—epithelium—primary biliary cirrhosis	0.00089	0.0136	CbGeAlD
Crizotinib—ACVR1B—liver—primary biliary cirrhosis	0.000884	0.0135	CbGeAlD
Crizotinib—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000882	0.00827	CcSEcCtD
Crizotinib—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000882	0.00827	CcSEcCtD
Crizotinib—EPHA2—epithelium—primary biliary cirrhosis	0.000879	0.0135	CbGeAlD
Crizotinib—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000874	0.0082	CcSEcCtD
Crizotinib—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000874	0.0082	CcSEcCtD
Crizotinib—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.000869	0.00815	CcSEcCtD
Crizotinib—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.000869	0.00815	CcSEcCtD
Crizotinib—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000869	0.00815	CcSEcCtD
Crizotinib—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000869	0.00815	CcSEcCtD
Crizotinib—Hypoaesthesia—Colchicine—primary biliary cirrhosis	0.000864	0.0081	CcSEcCtD
Crizotinib—EPHB4—smooth muscle tissue—primary biliary cirrhosis	0.000863	0.0132	CbGeAlD
Crizotinib—TEK—epithelium—primary biliary cirrhosis	0.000857	0.0131	CbGeAlD
Crizotinib—JAK2—smooth muscle tissue—primary biliary cirrhosis	0.000857	0.0131	CbGeAlD
Crizotinib—STK4—liver—primary biliary cirrhosis	0.000828	0.0127	CbGeAlD
Crizotinib—MAP4K5—smooth muscle tissue—primary biliary cirrhosis	0.000826	0.0127	CbGeAlD
Crizotinib—TEK—smooth muscle tissue—primary biliary cirrhosis	0.000826	0.0127	CbGeAlD
Crizotinib—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.000822	0.00771	CcSEcCtD
Crizotinib—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.000822	0.00771	CcSEcCtD
Crizotinib—Eye disorder—Colchicine—primary biliary cirrhosis	0.000811	0.00761	CcSEcCtD
Crizotinib—FER—liver—primary biliary cirrhosis	0.000782	0.012	CbGeAlD
Crizotinib—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.000782	0.00734	CcSEcCtD
Crizotinib—LYN—liver—primary biliary cirrhosis	0.000778	0.0119	CbGeAlD
Crizotinib—TNK1—liver—primary biliary cirrhosis	0.000774	0.0119	CbGeAlD
Crizotinib—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00077	0.00722	CcSEcCtD
Crizotinib—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00077	0.00722	CcSEcCtD
Crizotinib—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.000768	0.00721	CcSEcCtD
Crizotinib—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.000768	0.00721	CcSEcCtD
Crizotinib—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000765	0.00717	CcSEcCtD
Crizotinib—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000765	0.00717	CcSEcCtD
Crizotinib—YES1—smooth muscle tissue—primary biliary cirrhosis	0.000763	0.0117	CbGeAlD
Crizotinib—SRC—epithelium—primary biliary cirrhosis	0.000762	0.0117	CbGeAlD
Crizotinib—Malnutrition—Colchicine—primary biliary cirrhosis	0.000756	0.00709	CcSEcCtD
Crizotinib—IGF1R—liver—primary biliary cirrhosis	0.000752	0.0115	CbGeAlD
Crizotinib—TNK2—liver—primary biliary cirrhosis	0.000752	0.0115	CbGeAlD
Crizotinib—Visual impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.000752	0.00705	CcSEcCtD
Crizotinib—Visual impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.000752	0.00705	CcSEcCtD
Crizotinib—MAP4K2—liver—primary biliary cirrhosis	0.000741	0.0114	CbGeAlD
Crizotinib—SRC—smooth muscle tissue—primary biliary cirrhosis	0.000734	0.0112	CbGeAlD
Crizotinib—TIE1—liver—primary biliary cirrhosis	0.000731	0.0112	CbGeAlD
Crizotinib—STK3—liver—primary biliary cirrhosis	0.000731	0.0112	CbGeAlD
Crizotinib—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000729	0.00684	CcSEcCtD
Crizotinib—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000729	0.00684	CcSEcCtD
Crizotinib—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000724	0.00679	CcSEcCtD
Crizotinib—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000724	0.00679	CcSEcCtD
Crizotinib—AURKA—liver—primary biliary cirrhosis	0.000713	0.0109	CbGeAlD
Crizotinib—TESK1—liver—primary biliary cirrhosis	0.000707	0.0108	CbGeAlD
Crizotinib—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000703	0.00659	CcSEcCtD
Crizotinib—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000703	0.00659	CcSEcCtD
Crizotinib—Anaemia—Colchicine—primary biliary cirrhosis	0.000698	0.00655	CcSEcCtD
Crizotinib—Arrhythmia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000697	0.00654	CcSEcCtD
Crizotinib—Arrhythmia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000697	0.00654	CcSEcCtD
Crizotinib—MERTK—liver—primary biliary cirrhosis	0.000688	0.0105	CbGeAlD
Crizotinib—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.000679	0.00637	CcSEcCtD
Crizotinib—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.000679	0.00637	CcSEcCtD
Crizotinib—Leukopenia—Colchicine—primary biliary cirrhosis	0.000676	0.00634	CcSEcCtD
Crizotinib—LIMK2—liver—primary biliary cirrhosis	0.000672	0.0103	CbGeAlD
Crizotinib—NUAK2—liver—primary biliary cirrhosis	0.00067	0.0103	CbGeAlD
Crizotinib—ACVR1—liver—primary biliary cirrhosis	0.000665	0.0102	CbGeAlD
Crizotinib—FLT3—liver—primary biliary cirrhosis	0.000665	0.0102	CbGeAlD
Crizotinib—MAP3K12—liver—primary biliary cirrhosis	0.000665	0.0102	CbGeAlD
Crizotinib—CSF1R—smooth muscle tissue—primary biliary cirrhosis	0.000659	0.0101	CbGeAlD
Crizotinib—STK35—liver—primary biliary cirrhosis	0.000652	0.00999	CbGeAlD
Crizotinib—ABL2—liver—primary biliary cirrhosis	0.000635	0.00973	CbGeAlD
Crizotinib—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000628	0.00589	CcSEcCtD
Crizotinib—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000628	0.00589	CcSEcCtD
Crizotinib—BMP2K—liver—primary biliary cirrhosis	0.000627	0.00961	CbGeAlD
Crizotinib—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.000609	0.00571	CcSEcCtD
Crizotinib—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.000609	0.00571	CcSEcCtD
Crizotinib—Leukopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000608	0.0057	CcSEcCtD
Crizotinib—Leukopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000608	0.0057	CcSEcCtD
Crizotinib—Shock—Colchicine—primary biliary cirrhosis	0.000607	0.00569	CcSEcCtD
Crizotinib—PTK2B—liver—primary biliary cirrhosis	0.000606	0.00929	CbGeAlD
Crizotinib—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.000605	0.00567	CcSEcCtD
Crizotinib—RIPK2—liver—primary biliary cirrhosis	0.000601	0.00921	CbGeAlD
Crizotinib—Skin disorder—Colchicine—primary biliary cirrhosis	0.000599	0.00562	CcSEcCtD
Crizotinib—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000597	0.0056	CcSEcCtD
Crizotinib—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000597	0.0056	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000574	0.00538	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000574	0.00538	CcSEcCtD
Crizotinib—MAP3K2—liver—primary biliary cirrhosis	0.00057	0.00873	CbGeAlD
Crizotinib—TBK1—liver—primary biliary cirrhosis	0.000558	0.00855	CbGeAlD
Crizotinib—PTK2—liver—primary biliary cirrhosis	0.000558	0.00855	CbGeAlD
Crizotinib—TYK2—liver—primary biliary cirrhosis	0.000554	0.00849	CbGeAlD
Crizotinib—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000554	0.0052	CcSEcCtD
Crizotinib—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000554	0.0052	CcSEcCtD
Crizotinib—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000551	0.00516	CcSEcCtD
Crizotinib—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000551	0.00516	CcSEcCtD
Crizotinib—IRAK1—liver—primary biliary cirrhosis	0.000547	0.00838	CbGeAlD
Crizotinib—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.000545	0.00511	CcSEcCtD
Crizotinib—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.000545	0.00511	CcSEcCtD
Crizotinib—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000543	0.0051	CcSEcCtD
Crizotinib—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000543	0.0051	CcSEcCtD
Crizotinib—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000538	0.00505	CcSEcCtD
Crizotinib—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000538	0.00505	CcSEcCtD
Crizotinib—RPS6KB1—liver—primary biliary cirrhosis	0.000537	0.00822	CbGeAlD
Crizotinib—Decreased appetite—Colchicine—primary biliary cirrhosis	0.000536	0.00503	CcSEcCtD
Crizotinib—FGR—liver—primary biliary cirrhosis	0.000533	0.00817	CbGeAlD
Crizotinib—LCK—liver—primary biliary cirrhosis	0.000533	0.00817	CbGeAlD
Crizotinib—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000532	0.00499	CcSEcCtD
Crizotinib—Fatigue—Colchicine—primary biliary cirrhosis	0.000532	0.00499	CcSEcCtD
Crizotinib—AXL—liver—primary biliary cirrhosis	0.000531	0.00814	CbGeAlD
Crizotinib—ABL1—smooth muscle tissue—primary biliary cirrhosis	0.000521	0.00798	CbGeAlD
Crizotinib—SLK—liver—primary biliary cirrhosis	0.000511	0.00784	CbGeAlD
Crizotinib—EPHB4—liver—primary biliary cirrhosis	0.000508	0.00778	CbGeAlD
Crizotinib—JAK2—liver—primary biliary cirrhosis	0.000504	0.00773	CbGeAlD
Crizotinib—EPHA2—liver—primary biliary cirrhosis	0.000498	0.00763	CbGeAlD
Crizotinib—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000498	0.00467	CcSEcCtD
Crizotinib—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000498	0.00467	CcSEcCtD
Crizotinib—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000494	0.00463	CcSEcCtD
Crizotinib—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000494	0.00463	CcSEcCtD
Crizotinib—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000488	0.00457	CcSEcCtD
Crizotinib—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000488	0.00457	CcSEcCtD
Crizotinib—TEK—liver—primary biliary cirrhosis	0.000486	0.00745	CbGeAlD
Crizotinib—MAP3K3—liver—primary biliary cirrhosis	0.000486	0.00745	CbGeAlD
Crizotinib—MAP4K5—liver—primary biliary cirrhosis	0.000486	0.00745	CbGeAlD
Crizotinib—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.000482	0.00452	CcSEcCtD
Crizotinib—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.000482	0.00452	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000478	0.00449	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000478	0.00449	CcSEcCtD
Crizotinib—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000478	0.00448	CcSEcCtD
Crizotinib—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000478	0.00448	CcSEcCtD
Crizotinib—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000474	0.00444	CcSEcCtD
Crizotinib—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000474	0.00444	CcSEcCtD
Crizotinib—YES1—liver—primary biliary cirrhosis	0.000449	0.00688	CbGeAlD
Crizotinib—STK10—liver—primary biliary cirrhosis	0.000445	0.00682	CbGeAlD
Crizotinib—TAOK3—liver—primary biliary cirrhosis	0.000443	0.00679	CbGeAlD
Crizotinib—Asthenia—Colchicine—primary biliary cirrhosis	0.000443	0.00415	CcSEcCtD
Crizotinib—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000438	0.00411	CcSEcCtD
Crizotinib—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000438	0.00411	CcSEcCtD
Crizotinib—SRC—liver—primary biliary cirrhosis	0.000432	0.00662	CbGeAlD
Crizotinib—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000422	0.00396	CcSEcCtD
Crizotinib—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000398	0.00373	CcSEcCtD
Crizotinib—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000398	0.00373	CcSEcCtD
Crizotinib—Vomiting—Colchicine—primary biliary cirrhosis	0.000392	0.00368	CcSEcCtD
Crizotinib—Rash—Colchicine—primary biliary cirrhosis	0.000389	0.00365	CcSEcCtD
Crizotinib—Dermatitis—Colchicine—primary biliary cirrhosis	0.000389	0.00364	CcSEcCtD
Crizotinib—CSF1R—liver—primary biliary cirrhosis	0.000388	0.00594	CbGeAlD
Crizotinib—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000379	0.00356	CcSEcCtD
Crizotinib—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000379	0.00356	CcSEcCtD
Crizotinib—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00344	CcSEcCtD
Crizotinib—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00344	CcSEcCtD
Crizotinib—Nausea—Colchicine—primary biliary cirrhosis	0.000366	0.00344	CcSEcCtD
Crizotinib—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000352	0.0033	CcSEcCtD
Crizotinib—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000352	0.0033	CcSEcCtD
Crizotinib—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000349	0.00328	CcSEcCtD
Crizotinib—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000349	0.00328	CcSEcCtD
Crizotinib—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000349	0.00327	CcSEcCtD
Crizotinib—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000349	0.00327	CcSEcCtD
Crizotinib—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000329	0.00309	CcSEcCtD
Crizotinib—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000329	0.00309	CcSEcCtD
Crizotinib—ABL1—liver—primary biliary cirrhosis	0.000306	0.0047	CbGeAlD
Crizotinib—CYP3A5—liver—primary biliary cirrhosis	0.000179	0.00275	CbGeAlD
Crizotinib—ABCB1—epithelium—primary biliary cirrhosis	0.000168	0.00258	CbGeAlD
Crizotinib—CYP3A4—liver—primary biliary cirrhosis	0.000135	0.00206	CbGeAlD
Crizotinib—ABCB1—liver—primary biliary cirrhosis	9.53e-05	0.00146	CbGeAlD
Crizotinib—SRC—Signaling Pathways—CXCL9—primary biliary cirrhosis	5.73e-06	3.3e-05	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—CD80—primary biliary cirrhosis	5.71e-06	3.28e-05	CbGpPWpGaD
Crizotinib—BLK—Immune System—TYK2—primary biliary cirrhosis	5.71e-06	3.28e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—GOT1—primary biliary cirrhosis	5.71e-06	3.28e-05	CbGpPWpGaD
Crizotinib—FGR—Immune System—TYK2—primary biliary cirrhosis	5.69e-06	3.27e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PDHX—primary biliary cirrhosis	5.69e-06	3.27e-05	CbGpPWpGaD
Crizotinib—TYK2—Innate Immune System—NFKB1—primary biliary cirrhosis	5.66e-06	3.25e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—CCL5—primary biliary cirrhosis	5.61e-06	3.23e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—CCL5—primary biliary cirrhosis	5.61e-06	3.23e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	5.61e-06	3.23e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—CXCL10—primary biliary cirrhosis	5.59e-06	3.22e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—CD80—primary biliary cirrhosis	5.52e-06	3.17e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—CXCL10—primary biliary cirrhosis	5.52e-06	3.17e-05	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—TYK2—primary biliary cirrhosis	5.5e-06	3.17e-05	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—NFKB1—primary biliary cirrhosis	5.5e-06	3.16e-05	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—ALB—primary biliary cirrhosis	5.49e-06	3.16e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—CD79A—primary biliary cirrhosis	5.48e-06	3.15e-05	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—CD80—primary biliary cirrhosis	5.48e-06	3.15e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—CD40LG—primary biliary cirrhosis	5.45e-06	3.14e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—CD80—primary biliary cirrhosis	5.44e-06	3.13e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	5.44e-06	3.13e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CD40LG—primary biliary cirrhosis	5.43e-06	3.12e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—TAB1—primary biliary cirrhosis	5.38e-06	3.1e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ABCB4—primary biliary cirrhosis	5.35e-06	3.08e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—DLAT—primary biliary cirrhosis	5.35e-06	3.08e-05	CbGpPWpGaD
Crizotinib—SRC—Axon guidance—MMP9—primary biliary cirrhosis	5.33e-06	3.07e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—ELMO1—primary biliary cirrhosis	5.3e-06	3.05e-05	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—MMP9—primary biliary cirrhosis	5.24e-06	3.02e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—HIF1A—primary biliary cirrhosis	5.24e-06	3.01e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CXCL10—primary biliary cirrhosis	5.23e-06	3.01e-05	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—MMP9—primary biliary cirrhosis	5.22e-06	3e-05	CbGpPWpGaD
Crizotinib—JAK3—Immune System—NFKB1—primary biliary cirrhosis	5.19e-06	2.98e-05	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—NFKB1—primary biliary cirrhosis	5.19e-06	2.98e-05	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—MMP9—primary biliary cirrhosis	5.19e-06	2.98e-05	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—AGT—primary biliary cirrhosis	5.17e-06	2.97e-05	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—NFKB1—primary biliary cirrhosis	5.16e-06	2.97e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—CD80—primary biliary cirrhosis	5.16e-06	2.97e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—HIF1A—primary biliary cirrhosis	5.15e-06	2.96e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—AGT—primary biliary cirrhosis	5.13e-06	2.95e-05	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—NFKB1—primary biliary cirrhosis	5.13e-06	2.95e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—GOT2—primary biliary cirrhosis	5.13e-06	2.95e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CD40LG—primary biliary cirrhosis	5.1e-06	2.94e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—MMP3—primary biliary cirrhosis	5.1e-06	2.93e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—CD80—primary biliary cirrhosis	5.1e-06	2.93e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—CTLA4—primary biliary cirrhosis	5.09e-06	2.93e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CXCL10—primary biliary cirrhosis	5.08e-06	2.92e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—HIF1A—primary biliary cirrhosis	5.08e-06	2.92e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—MMP2—primary biliary cirrhosis	5.06e-06	2.91e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—AGT—primary biliary cirrhosis	5.06e-06	2.91e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—CD80—primary biliary cirrhosis	5.05e-06	2.91e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—MMP3—primary biliary cirrhosis	5.03e-06	2.89e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—CD80—primary biliary cirrhosis	5.01e-06	2.88e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—GOT1—primary biliary cirrhosis	5e-06	2.88e-05	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—MMP9—primary biliary cirrhosis	4.91e-06	2.82e-05	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—ALB—primary biliary cirrhosis	4.86e-06	2.8e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—HIF1A—primary biliary cirrhosis	4.86e-06	2.79e-05	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—NFKB1—primary biliary cirrhosis	4.86e-06	2.79e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—CD79A—primary biliary cirrhosis	4.86e-06	2.79e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—CD80—primary biliary cirrhosis	4.85e-06	2.79e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—AGT—primary biliary cirrhosis	4.84e-06	2.78e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—TYK2—primary biliary cirrhosis	4.83e-06	2.78e-05	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—TYK2—primary biliary cirrhosis	4.82e-06	2.77e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—CCL5—primary biliary cirrhosis	4.81e-06	2.77e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—MMP3—primary biliary cirrhosis	4.77e-06	2.74e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—NOS2—primary biliary cirrhosis	4.77e-06	2.74e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—TAB1—primary biliary cirrhosis	4.77e-06	2.74e-05	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	4.76e-06	2.74e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—CCL5—primary biliary cirrhosis	4.75e-06	2.73e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—HIF1A—primary biliary cirrhosis	4.71e-06	2.71e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—AGT—primary biliary cirrhosis	4.69e-06	2.7e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—AGT—primary biliary cirrhosis	4.69e-06	2.7e-05	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—MMP9—primary biliary cirrhosis	4.69e-06	2.7e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	4.67e-06	2.68e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—TYK2—primary biliary cirrhosis	4.66e-06	2.68e-05	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—NFKB1—primary biliary cirrhosis	4.64e-06	2.67e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—MMP3—primary biliary cirrhosis	4.63e-06	2.66e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—CD80—primary biliary cirrhosis	4.63e-06	2.66e-05	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—NFKB1—primary biliary cirrhosis	4.62e-06	2.66e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	4.6e-06	2.65e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—TYK2—primary biliary cirrhosis	4.59e-06	2.64e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—MMP9—primary biliary cirrhosis	4.59e-06	2.64e-05	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—NFKB1—primary biliary cirrhosis	4.58e-06	2.64e-05	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—NFKB1—primary biliary cirrhosis	4.56e-06	2.62e-05	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—NFKB1—primary biliary cirrhosis	4.56e-06	2.62e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—CD80—primary biliary cirrhosis	4.55e-06	2.61e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—NFKB1—primary biliary cirrhosis	4.54e-06	2.61e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CCL5—primary biliary cirrhosis	4.5e-06	2.59e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—CD80—primary biliary cirrhosis	4.48e-06	2.58e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—CD40LG—primary biliary cirrhosis	4.47e-06	2.57e-05	CbGpPWpGaD
Crizotinib—BLK—Immune System—NFKB1—primary biliary cirrhosis	4.45e-06	2.56e-05	CbGpPWpGaD
Crizotinib—FGR—Immune System—NFKB1—primary biliary cirrhosis	4.43e-06	2.55e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—GOT1—primary biliary cirrhosis	4.43e-06	2.55e-05	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—NFKB1—primary biliary cirrhosis	4.4e-06	2.53e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CCL5—primary biliary cirrhosis	4.37e-06	2.51e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	4.36e-06	2.51e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—TYK2—primary biliary cirrhosis	4.36e-06	2.51e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—TYK2—primary biliary cirrhosis	4.31e-06	2.48e-05	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—NFKB1—primary biliary cirrhosis	4.29e-06	2.47e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—CD80—primary biliary cirrhosis	4.29e-06	2.47e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—TYK2—primary biliary cirrhosis	4.27e-06	2.45e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—NUP210—primary biliary cirrhosis	4.26e-06	2.45e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	4.24e-06	2.44e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—CD80—primary biliary cirrhosis	4.16e-06	2.39e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CXCL10—primary biliary cirrhosis	4.11e-06	2.37e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—CD80—primary biliary cirrhosis	4.06e-06	2.33e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—HIF1A—primary biliary cirrhosis	4.04e-06	2.32e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CD80—primary biliary cirrhosis	4.04e-06	2.32e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—AGT—primary biliary cirrhosis	4.03e-06	2.32e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—HIF1A—primary biliary cirrhosis	3.99e-06	2.29e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—HIF1A—primary biliary cirrhosis	3.97e-06	2.28e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—AGT—primary biliary cirrhosis	3.97e-06	2.28e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—ABCG2—primary biliary cirrhosis	3.96e-06	2.28e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—CD40LG—primary biliary cirrhosis	3.96e-06	2.28e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	3.93e-06	2.26e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CXCL10—primary biliary cirrhosis	3.85e-06	2.21e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—TYK2—primary biliary cirrhosis	3.84e-06	2.21e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—MMP9—primary biliary cirrhosis	3.81e-06	2.19e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CD80—primary biliary cirrhosis	3.8e-06	2.18e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—TYK2—primary biliary cirrhosis	3.78e-06	2.18e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—HIF1A—primary biliary cirrhosis	3.78e-06	2.17e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—AGT—primary biliary cirrhosis	3.77e-06	2.17e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—NFKB1—primary biliary cirrhosis	3.76e-06	2.17e-05	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—NFKB1—primary biliary cirrhosis	3.76e-06	2.16e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—MMP3—primary biliary cirrhosis	3.75e-06	2.16e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—HIF1A—primary biliary cirrhosis	3.67e-06	2.11e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—AGT—primary biliary cirrhosis	3.66e-06	2.1e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—NFKB1—primary biliary cirrhosis	3.63e-06	2.09e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TYK2—primary biliary cirrhosis	3.62e-06	2.08e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—NOS2—primary biliary cirrhosis	3.61e-06	2.08e-05	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—NFKB1—primary biliary cirrhosis	3.61e-06	2.07e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—NFKB1—primary biliary cirrhosis	3.58e-06	2.06e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—CD80—primary biliary cirrhosis	3.57e-06	2.05e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CCL5—primary biliary cirrhosis	3.54e-06	2.04e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—CD80—primary biliary cirrhosis	3.52e-06	2.02e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—MMP3—primary biliary cirrhosis	3.51e-06	2.02e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TYK2—primary biliary cirrhosis	3.51e-06	2.02e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—TYK2—primary biliary cirrhosis	3.51e-06	2.02e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—CD80—primary biliary cirrhosis	3.51e-06	2.02e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	3.5e-06	2.02e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—HIF1A—primary biliary cirrhosis	3.48e-06	2e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	3.43e-06	1.97e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—TYK2—primary biliary cirrhosis	3.43e-06	1.97e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—TYK2—primary biliary cirrhosis	3.41e-06	1.96e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CTGF—primary biliary cirrhosis	3.4e-06	1.95e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—NFKB1—primary biliary cirrhosis	3.39e-06	1.95e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—MMP9—primary biliary cirrhosis	3.39e-06	1.95e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CXCL10—primary biliary cirrhosis	3.37e-06	1.94e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GOT2—primary biliary cirrhosis	3.37e-06	1.94e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.35e-06	1.93e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CD80—primary biliary cirrhosis	3.34e-06	1.92e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—CD80—primary biliary cirrhosis	3.33e-06	1.91e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—NFKB1—primary biliary cirrhosis	3.32e-06	1.91e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CCL5—primary biliary cirrhosis	3.31e-06	1.91e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—NFKB1—primary biliary cirrhosis	3.3e-06	1.9e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	3.3e-06	1.9e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	3.3e-06	1.9e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CD80—primary biliary cirrhosis	3.24e-06	1.86e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	3.21e-06	1.85e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	3.21e-06	1.85e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—TYK2—primary biliary cirrhosis	3.21e-06	1.84e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—NFKB1—primary biliary cirrhosis	3.19e-06	1.84e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—NOS2—primary biliary cirrhosis	3.16e-06	1.82e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—HIF1A—primary biliary cirrhosis	3.08e-06	1.77e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—MMP3—primary biliary cirrhosis	3.07e-06	1.77e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—CD80—primary biliary cirrhosis	3.07e-06	1.77e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—MMP9—primary biliary cirrhosis	3.02e-06	1.74e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TYK2—primary biliary cirrhosis	3.01e-06	1.73e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.99e-06	1.72e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	2.99e-06	1.72e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CXCL10—primary biliary cirrhosis	2.98e-06	1.72e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—MMP9—primary biliary cirrhosis	2.98e-06	1.71e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HIF1A—primary biliary cirrhosis	2.97e-06	1.71e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TYK2—primary biliary cirrhosis	2.97e-06	1.71e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—AGT—primary biliary cirrhosis	2.96e-06	1.7e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—TYK2—primary biliary cirrhosis	2.96e-06	1.7e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.95e-06	1.7e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—CD80—primary biliary cirrhosis	2.94e-06	1.69e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GGT1—primary biliary cirrhosis	2.91e-06	1.67e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GOT1—primary biliary cirrhosis	2.91e-06	1.67e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CCL5—primary biliary cirrhosis	2.9e-06	1.67e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—MMP9—primary biliary cirrhosis	2.85e-06	1.64e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.82e-06	1.62e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TYK2—primary biliary cirrhosis	2.82e-06	1.62e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	2.81e-06	1.62e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—TYK2—primary biliary cirrhosis	2.81e-06	1.61e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—NOS2—primary biliary cirrhosis	2.8e-06	1.61e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HIF1A—primary biliary cirrhosis	2.78e-06	1.6e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—AGT—primary biliary cirrhosis	2.77e-06	1.59e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—MMP9—primary biliary cirrhosis	2.76e-06	1.59e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.73e-06	1.57e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MMP3—primary biliary cirrhosis	2.72e-06	1.57e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—CD80—primary biliary cirrhosis	2.72e-06	1.56e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—NFKB1—primary biliary cirrhosis	2.67e-06	1.53e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—NFKB1—primary biliary cirrhosis	2.66e-06	1.53e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CD80—primary biliary cirrhosis	2.62e-06	1.51e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—TYK2—primary biliary cirrhosis	2.59e-06	1.49e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PPARGC1A—primary biliary cirrhosis	2.59e-06	1.49e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CCL5—primary biliary cirrhosis	2.57e-06	1.48e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	2.56e-06	1.47e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	2.54e-06	1.46e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—NFKB1—primary biliary cirrhosis	2.5e-06	1.44e-05	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	2.49e-06	1.43e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	2.49e-06	1.43e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—TYK2—primary biliary cirrhosis	2.49e-06	1.43e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CD80—primary biliary cirrhosis	2.45e-06	1.41e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HIF1A—primary biliary cirrhosis	2.44e-06	1.4e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—AGT—primary biliary cirrhosis	2.43e-06	1.4e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—MMP9—primary biliary cirrhosis	2.37e-06	1.36e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.35e-06	1.35e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—MMP9—primary biliary cirrhosis	2.34e-06	1.35e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.31e-06	1.33e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—TYK2—primary biliary cirrhosis	2.29e-06	1.32e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—MMP9—primary biliary cirrhosis	2.22e-06	1.28e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TYK2—primary biliary cirrhosis	2.21e-06	1.27e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.19e-06	1.26e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	2.19e-06	1.26e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	2.19e-06	1.26e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—NFKB1—primary biliary cirrhosis	2.19e-06	1.26e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HIF1A—primary biliary cirrhosis	2.16e-06	1.24e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—MMP9—primary biliary cirrhosis	2.15e-06	1.24e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CD80—primary biliary cirrhosis	2.15e-06	1.24e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—AGT—primary biliary cirrhosis	2.15e-06	1.24e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.13e-06	1.23e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TYK2—primary biliary cirrhosis	2.07e-06	1.19e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—AGT—primary biliary cirrhosis	2.01e-06	1.16e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	1.98e-06	1.14e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	1.95e-06	1.12e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—NFKB1—primary biliary cirrhosis	1.94e-06	1.11e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CD80—primary biliary cirrhosis	1.9e-06	1.09e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	1.84e-06	1.06e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TYK2—primary biliary cirrhosis	1.82e-06	1.04e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—MMP9—primary biliary cirrhosis	1.74e-06	1e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.73e-06	9.92e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—MMP9—primary biliary cirrhosis	1.63e-06	9.39e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.61e-06	9.29e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TYK2—primary biliary cirrhosis	1.61e-06	9.24e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	1.58e-06	9.09e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	1.57e-06	9e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—ALB—primary biliary cirrhosis	1.55e-06	8.89e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—AGT—primary biliary cirrhosis	1.52e-06	8.74e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—MMP9—primary biliary cirrhosis	1.43e-06	8.22e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.41e-06	8.13e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	1.35e-06	7.77e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	1.35e-06	7.77e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MMP9—primary biliary cirrhosis	1.27e-06	7.28e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.25e-06	7.2e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	1.2e-06	6.92e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ALB—primary biliary cirrhosis	1.17e-06	6.71e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	9.37e-07	5.39e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	7.19e-07	4.13e-06	CbGpPWpGaD
